Not logged in Share Save
Share Save
Share Save
Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 'I of the MOVES-PD study Peterschmitt, M. Judith; Saiki, Hidemoto; Hatano, Taku; Gasser, Thomas; Isaacson, Stuart; Kulisevsky, Jaime; Simuni, Tanya; Takahashi, Yuji; Wills, Anne-Marie; Guedes, Leonor Correia; Svenningsson, Per; Takahashi, Ryosuke; Waters, Cheryl; Katsuno, Masahisa; Ji, Allena Ji; Gaemers, Sebastiaan J. M.; Minini, Pascal; Nembo, Blandine; Sardi, Pablo; Saubadu, Stephane; Sharma, Jyoti; Fischer, Tanya Share Save
Venglustat combined with imiglucerase positively affects neurological features and brain connectivity in adults with Gaucher disease type 3 Schiffmann, Raphael; Cox, Timothy M.; Ida, Hiroyuki; Mengel, Eugen; Mistry, Pramod; Crawford, Nigel; Gaemers, Sebastiaan; Ji, Allena; Peterschmitt, M. Judith; Sharma, Jyoti; Zhang, Qi; Fischer, Tanya Share Save
Share Save
Share Save
Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation Peterschmitt, M. Judith; Gasser, Thomas; Isaacson, Stuart; Kulisevsky, Jaime; Mir, Pablo; Simuni, Tanya; Wills, Anne-Marie; Guedes, Leonor Correia; Svenningsson, Per; Waters, Cheryl; Ji, Allena J.; Li, Jian; Minini, Pascal; Nembo, Blandine; Saubadu, Stephane; Sharma, Jyoti; Fischer, Tanya Share Save
Share Save
Share Save
Share Save
Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis Hennan, JK; Elokdah, H; Leal, M; Ji, A; Friedrichs, GS; Morgan, GA; Swillo, RE; Antrilli, TM; Hreha, A; Crandall, DL Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}